Collectively, these results suggested that AFAP1‐AS1 could promote the invasion, metastasis, and glycolytic ability of CRC cells, and may contribute to cancer progression by regulating aerobic glycolysis. The gene discussed is AFAP1; the disease is colorectal carcinoma.